Patents Assigned to Cognis Australia Pty., Ltd.
  • Patent number: 6428816
    Abstract: A method of inhibiting carcinogen mediated conversion of melanocyte cells and protecting DNA against carcinogen-mediated damage by administering a composition comprising a water insoluble carotenoid such as beta-carotene is disclosed.
    Type: Grant
    Filed: January 16, 1997
    Date of Patent: August 6, 2002
    Assignee: Cognis Australia Pty., Ltd.
    Inventors: Lance Elliot Schlipalius, Julie A. Buckmeier, Frank L. Meyskens, Jr.